Drugs.com - Pharma Industry News

Weekly LYN-005 Provides Sustained Risperidone Release in Schizophrenia

WEDNESDAY, June 18, 2025 -- For patients with schizophrenia, weekly LYN-005 provides sustained release of risperidone at therapeutic concentrations, according to a study published online June 11 in The Lancet Psychiatry.Leslie Citrome, M.D., from...

Jun 18, 2025 - 19:00
 0
Weekly LYN-005 Provides Sustained Risperidone Release in Schizophrenia
WEDNESDAY, June 18, 2025 -- For patients with schizophrenia, weekly LYN-005 provides sustained release of risperidone at therapeutic concentrations, according to a study published online June 11 in The Lancet Psychiatry.Leslie Citrome, M.D., from...
Read More

Tags:

Previous Article

Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis

Next Article

Electroconvulsive Therapy Reduces Mortality in People With Depression

Related Posts

Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis

Waist-to-Height Ratio Predicts Liver Steatosis and Fibr...

Jun 18, 2025  0

Risk for Postpartum Psychosis Higher When Full Sibling Has Experienced It

Risk for Postpartum Psychosis Higher When Full Sibling ...

May 29, 2025  0

Adverse Childhood Experiences Tied to Endometriosis Risk

Adverse Childhood Experiences Tied to Endometriosis Risk

Jun 13, 2025  0